Albert David Ltd
Fri 21/08/2026,15:52:13 | NSE : ALBERTDAVD
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 869.90
Previous Close
₹ 863.15
Volume
8329
Mkt Cap ( ₹ Cr)
₹ 493.18
High
₹ 870.00
Low
₹ 850.05
52 Week High
₹ 903.00
52 Week Low
₹ 579.90
Book Value Per Share
₹ 742.11
Dividend Yield
0.57
Face Value
₹ 10.00
What's Your Call?
Collective community sentiment on Albert David Ltd
Your Vote -
Buy
81.82%
Hold
9.09%
Sell
9.09%
81.82%
22 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
0%
Sell Order Quantity
100%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
864.15
263
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
263
Option Chain
Analyzes market sentiment, predicts Albert David Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Albert David Q1 net profit zooms 303.02% at Rs 32.00 cr
-
Albert David - Shareholders meeting
-
Albert David - Voting Results For The 87Th Annual General Meeting Of The Company.
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Copy of Newspaper Publication
-
Albert David - Shareholders meeting
-
Albert David - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Change in Management
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Announcement under Regulation 30 (LODR)-Change in Management
-
Albert David - Outcome of Board Meeting
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Board Meeting Outcome for Outcome Of Board Meeting Dated 06.08.2026
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Albert David - Copy of Newspaper Publication
-
Albert David - Board Meeting Intimation for To Consider, Approve\r\nAnd Take On Record The Unaudited Financial Results Of The
-
Albert David has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Albert David - General Updates
-
Albert David - Pursuant To Regulation 36(1)(B) Of SEBI Listing Regulations, 2015, The Company Has Completed The Dispatch Of T
-
Albert David - Copy of Newspaper Publication
-
Albert David - Shareholders meeting
-
Albert David - Reg. 34 (1) Annual Report.
-
Albert David - 87Th AGM Has Been Scheduled On 6Th August, 2026 At 9:30 A.M.
-
Albert David - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Change in Management
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Albert David - Announcement under Regulation 30 (LODR)-Change in Management
-
Albert David - Copy of Newspaper Publication
-
Albert David - Credit Rating
-
Albert David - Trading Window
-
Albert David - Change in Director(s)
-
Albert David - Change in Management
-
Albert David - Outcome of Board Meeting
-
Albert David - Announcement under Regulation 30 (LODR)-Change in Management
-
Albert David - Board Meeting Outcome for Appointment Of Mr. Amit Mahla As An Additional Director And Whole-Time Director & C
-
Albert David - Copy of Newspaper Publication
-
Albert David has declared 50% Final dividend for the financial year March 2026
-
Albert David - Resignation
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Resignation of Director/KMP/SMP
-
Albert David - Announcement under Regulation 30 (LODR)-Change in Management
Key fundamentals
Evaluate the intrinsic value of Albert David Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 420.0139 | 402.5326 | 385.0809 | 315.5417 | 283.2368 |
| Liabilities | 420.0139 | 402.5326 | 385.0809 | 315.5417 | 283.2368 |
| Equity | 5.7072 | 5.7072 | 5.7072 | 5.7072 | 5.7072 |
| Gross Profit | 5.4666 | 3.0263 | 46.8796 | 44.3433 | 40.7942 |
| Net Profit | -1.4947 | 17.2008 | 75.4201 | 36.1749 | 35.2583 |
| Cash From Operating Activities | -7.6584 | -28.4358 | 45.5022 | 10.515 | 40.3647 |
| NPM(%) | -0.44 | 4.97 | 20.8 | 10.59 | 11.24 |
| Revenue | 333.5981 | 345.768 | 362.4617 | 341.5644 | 313.5114 |
| Expenses | 328.1315 | 342.7417 | 315.5821 | 297.2211 | 272.7172 |
| ROE(%) | -0.35 | 4.06 | 17.8 | 8.54 | 8.32 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 30 Jul 2026 | 5 | 50 | 0.58 | 781.1 |
| 25 Jul 2025 | 5 | 50 | 0.58 | 884 |
| 02 Aug 2024 | 11.5 | 115 | 0.58 | 1201.95 |
| 03 Aug 2023 | 9 | 90 | 0.58 | 596.4 |
| 01 Aug 2022 | 9 | 90 | 0.58 | 545.85 |
| 06 Sep 2021 | 6 | 60 | 0.58 | 513.4 |
| 13 Mar 2020 | 7 | 70 | 0.58 | 411.35 |
| 01 Aug 2019 | 6 | 60 | 0.58 | 490.55 |
| 24 Aug 2018 | 5.5 | 55 | 0.58 | 388 |
| 01 Sep 2017 | 5.5 | 55 | 0.58 | 316.55 |
Peers
Other companies within the same industry or sector that are comparable to Albert David Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Lotus Eye Hospital and Institute Ltd | 115.60 | -1.29 | 1651.43 | 1794.41 | 0.39 | 0.00 |
| Vaishali Pharma Ltd | 7.99 | 0.50 | 24.97 | 11256.92 | 15.42 | 0.00 |
| Astec Lifesciences Ltd | 601.85 | 0.01 | 0.00 | 1922.61 | -363.14 | 0.00 |
| Suraksha Diagnostic Ltd | 325.80 | 6.77 | 47.42 | 4493.81 | 309.01 | 0.00 |
Company Info
The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.
The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.
Read More
Parent Organisation
Albert David Ltd.
Founded
16/11/1938
Managing Director
NSE Symbol
ALBERTDAVDEQ
FAQ
The current price of Albert David Ltd is ₹ 864.15.
The 52-week high for Albert David Ltd is ₹ 870.00 and the 52-week low is ₹ 850.05.
The market capitalization of Albert David Ltd is currently ₹ 493.18. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Albert David Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Albert David Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Albert David Ltd shares.
The CEO of Albert David Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
